NONOF - Novo Nordisk GAAP EPS of DKK 5.00 revenue of DKK 58.73B; raises FY23 sales guidance
2023-11-02 02:41:41 ET
More on Novo Nordisk:
- Novo Nordisk Milks The Obesity Cash Cow - How Long Will It Last?
- Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion
- Novo Nordisk: DCF Analysis Suggests Significant Undervaluation
- Belgium mulls short-term ban on use of Novo Nordisk’s Ozempic for weight loss
- Eli Lilly, Novo eyeing obesity meds for kids as young as six
For further details see:
Novo Nordisk GAAP EPS of DKK 5.00, revenue of DKK 58.73B; raises FY23 sales guidance